Yingqiang Guo

700 total citations
47 papers, 417 citations indexed

About

Yingqiang Guo is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yingqiang Guo has authored 47 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 23 papers in Pulmonary and Respiratory Medicine and 20 papers in Epidemiology. Recurrent topics in Yingqiang Guo's work include Cardiac Valve Diseases and Treatments (29 papers), Aortic Disease and Treatment Approaches (18 papers) and Infective Endocarditis Diagnosis and Management (18 papers). Yingqiang Guo is often cited by papers focused on Cardiac Valve Diseases and Treatments (29 papers), Aortic Disease and Treatment Approaches (18 papers) and Infective Endocarditis Diagnosis and Management (18 papers). Yingqiang Guo collaborates with scholars based in China, United States and France. Yingqiang Guo's co-authors include Da Zhu, Jia Hu, Lulu Liu, Lai Wei, Hong Qian, Yingkang Shi, Jun Shi, Hua Fu, Chaoyi Qin and Wenchao Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and ACS Nano.

In The Last Decade

Yingqiang Guo

42 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingqiang Guo China 13 281 195 165 76 38 47 417
Benjamin S. Frank United States 13 225 0.8× 153 0.8× 323 2.0× 164 2.2× 50 1.3× 64 543
Gianluca Lucchese United Kingdom 9 194 0.7× 141 0.7× 125 0.8× 101 1.3× 57 1.5× 40 350
Paolo Ferraro Italy 10 224 0.8× 115 0.6× 74 0.4× 112 1.5× 71 1.9× 51 403
Takao Konishi Japan 13 214 0.8× 52 0.3× 91 0.6× 138 1.8× 27 0.7× 71 388
Runlin Gao China 13 332 1.2× 118 0.6× 136 0.8× 264 3.5× 44 1.2× 53 565
Mitsuhiro Yamamura Japan 13 234 0.8× 104 0.5× 178 1.1× 216 2.8× 59 1.6× 86 481
Yunhu Song China 13 345 1.2× 92 0.5× 54 0.3× 166 2.2× 53 1.4× 44 456
Masaaki Ryomoto Japan 13 311 1.1× 108 0.6× 210 1.3× 298 3.9× 49 1.3× 81 537
Mengyue Yu China 14 221 0.8× 77 0.4× 61 0.4× 164 2.2× 30 0.8× 29 430
Shuming Wu China 12 90 0.3× 61 0.3× 156 0.9× 96 1.3× 77 2.0× 31 379

Countries citing papers authored by Yingqiang Guo

Since Specialization
Citations

This map shows the geographic impact of Yingqiang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqiang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqiang Guo more than expected).

Fields of papers citing papers by Yingqiang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingqiang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqiang Guo. The network helps show where Yingqiang Guo may publish in the future.

Co-authorship network of co-authors of Yingqiang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yingqiang Guo. A scholar is included among the top collaborators of Yingqiang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqiang Guo. Yingqiang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Qiu, Yan Deng, Yuying Feng, et al.. (2025). Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy. Proceedings of the National Academy of Sciences. 122(18). e2423432122–e2423432122.
2.
Xiang, Lisha, Yang Yang, Lulu Zhang, et al.. (2025). A20 attenuates oxidized self-DNA-mediated inflammation in acute kidney injury. Signal Transduction and Targeted Therapy. 10(1). 154–154. 3 indexed citations
3.
Wang, Yuqiang, Lai Wei, Lulu Liu, et al.. (2025). A multicenter prospective clinical study on transcatheter aortic valve implantation for aortic stenosis or pure aortic regurgitation: 5-year outcomes. Journal of Thoracic and Cardiovascular Surgery. 170(5). 1379–1391.e3.
5.
Jiang, Yunhan, Xiaoqiu Xu, Dongmei Fan, et al.. (2024). Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate. Journal of Medicinal Chemistry. 67(16). 13959–13974. 11 indexed citations
6.
Liu, Yang, Mengen Zhai, Ping Jin, et al.. (2024). Transapical Transcatheter Aortic Valve Replacement Under 3-Dimensional Guidance to Treat Pure Aortic Regurgitation in Patients with a Large Aortic Annulus. Reviews in Cardiovascular Medicine. 25(9). 319–319.
7.
Zhang, Xiaochun, Qinchun Jin, Wenzhi Pan, et al.. (2023). First-in-human study of the K-Clip™ transcatheter annular repair system for severe functional tricuspid regurgitation. International Journal of Cardiology. 390. 131174–131174. 9 indexed citations
8.
He, Siyu, et al.. (2023). The Management and Antithrombotic Strategies of Patients with Coronary Artery Disease and High Bleeding Risk. Current Cardiology Reports. 25(7). 669–680. 2 indexed citations
10.
Liu, Lulu, Ying Peng, Weina Huang, et al.. (2022). One‐year outcome after transcatheter aortic valve replacement for aortic regurgitation: A single‐center study. Journal of Cardiac Surgery. 37(4). 882–892. 6 indexed citations
12.
Liu, Lulu, Sai Chen, Jun Shi, Chaoyi Qin, & Yingqiang Guo. (2020). Transcatheter Aortic Valve Replacement in Aortic Regurgitation. The Annals of Thoracic Surgery. 110(6). 1959–1965. 13 indexed citations
13.
Chen, Jinmiao, Chen He, Minzhi Lv, et al.. (2020). One-year outcome with a bovine pericardial valve. JTCVS Open. 2. 1–11. 2 indexed citations
15.
Wang, Xu, Fei Li, Yingqiang Guo, et al.. (2018). A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. Journal of Cardiology. 72(5). 377–384. 16 indexed citations
16.
Liu, Huan, Ye Yang, Wenshuo Wang, et al.. (2018). Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve. Journal of Thoracic and Cardiovascular Surgery. 156(1). 106–116. 32 indexed citations
17.
Zhu, Li, Yingqiang Guo, Wei Wang, et al.. (2017). Transapical transcatheter aortic valve replacement with a novel transcatheter aortic valve replacement system in high-risk patients with severe aortic valve diseases. Journal of Thoracic and Cardiovascular Surgery. 155(2). 588–597. 21 indexed citations
18.
Guo, Yingqiang & Da Zhu. (2015). TCT-105 Transcatheter aortic valve implantation using a new second-generation TAVI system: J-ValveTM for high-risk patients with pure aortic regurgitation. Journal of the American College of Cardiology. 66(15). B48–B49. 7 indexed citations
19.
Fu, Hua, Lingjun Zhang, He Huang, et al.. (2010). Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biology. 11(1). 36–36. 55 indexed citations
20.
Ren, Fuqiang, et al.. (2009). [Modification of the method for establishing myocardial infarction model in rats].. PubMed. 26(6). 1291–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026